title: Rising like the phoenix?
authors.affiliation: From the Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, OH. plowe@ccf.org.
authors.forename: Edward F
authors.initials: EF
authors.lastname: Plow
authors.affiliation: From the Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, OH.
authors.forename: Mitali
authors.initials: M
authors.lastname: Das
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000187:drug effects*; D016893:Carotid Stenosis / Q000517:prevention & control*; D004632:Emergency Medical Services; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011744:Pyrimidinones / Q000494:pharmacology*; D013830:Thiadiazoles / Q000494:pharmacology*; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011744:Pyrimidinones; C000593083:RUC-4 compound; D013830:Thiadiazoles
keywords: platelet; platelet aggregation; thrombosis; αIIbβ3; αIIbβ3 antagonist